Apigenin alleviates neuroinflammation in a mouse model of Parkinson's disease
Purpose of the study The aim of this study is to evaluate the effect of apigenin on
inflammatory response in brain tissue in Parkinson's mouse model. Materials and methods …
inflammatory response in brain tissue in Parkinson's mouse model. Materials and methods …
Anti-inflammatory and neuroprotective effect of apigenin: studies in the GFAP-IL6 mouse model of chronic neuroinflammation
Background Chronic neuroinflammation (activation of microglia and astrocytes) is a
prominent pathological process in many neurodegenerative diseases including Alzheimer's …
prominent pathological process in many neurodegenerative diseases including Alzheimer's …
Protection of MPTP-induced neuroinflammation and neurodegeneration by Pycnogenol
MM Khan, D Kempuraj, R Thangavel… - Neurochemistry …, 2013 - Elsevier
Oxidative stress and inflammation play a crucial role in Parkinson's disease (PD)
pathogenesis and may represent a target for treatment. Current PD drugs provide only …
pathogenesis and may represent a target for treatment. Current PD drugs provide only …
Escin attenuates behavioral impairments, oxidative stress and inflammation in a chronic MPTP/probenecid mouse model of Parkinson׳ s disease
GP Selvakumar, U Janakiraman, MM Essa… - Brain research, 2014 - Elsevier
Parkinson׳ s disease (PD) is a progressive neurodegenerative disorder that results mainly
due to the death of dopaminergic neurons in the substantia nigra (SN), and subsequently …
due to the death of dopaminergic neurons in the substantia nigra (SN), and subsequently …
Eupatilin prevents behavioral deficits and dopaminergic neuron degeneration in a Parkinson's disease mouse model
Y Zhang, L Qin, J Xie, J Li, C Wang - Life sciences, 2020 - Elsevier
Aims Neuroinflammation and apoptosis play a crucial role in Parkinson's disease (PD)
pathogenesis. Eupatilin is a lipophilic flavonoid isolated from Artemisia species and exerts …
pathogenesis. Eupatilin is a lipophilic flavonoid isolated from Artemisia species and exerts …
Apigenin attenuates functional and structural alterations via targeting NF-kB/Nrf2 signaling pathway in LPS-induced parkinsonism in experimental rats: Apigenin …
M Patel, S Singh - Neurotoxicity Research, 2022 - Springer
Parkinson's disease (PD) is a progressive hypokinetic movement disorder caused by
selective degeneration of dopaminergic neurons in striatum and dopamine deficiency in a …
selective degeneration of dopaminergic neurons in striatum and dopamine deficiency in a …
[HTML][HTML] Arbutin effectively ameliorates the symptoms of Parkinson's disease: the role of adenosine receptors and cyclic adenosine monophosphate
J Zhao, M Kumar, J Sharma, Z Yuan - Neural regeneration …, 2021 - journals.lww.com
An antagonistic communication exists between adenosinergic and dopaminergic signaling
in the basal ganglia, which suggests that the suppression of adenosine A 2A receptors …
in the basal ganglia, which suggests that the suppression of adenosine A 2A receptors …
[HTML][HTML] Neuroprotective effects of piperine on the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced Parkinson's disease mouse model
W Yang, YH Chen, H Liu… - … journal of molecular …, 2015 - spandidos-publications.com
Parkinson's disease (PD) is second only to Alzheimer's disease as the most common and
debilitating age-associated neurodegenerative disorder. Currently, no therapy has been …
debilitating age-associated neurodegenerative disorder. Currently, no therapy has been …
L-Theanine alleviates MPTP-induced Parkinson's disease by targeting Wnt/β-catenin signaling mediated by the MAPK signaling pathway
K Ratih, YR Lee, KH Chung, KJ Lee, DH Kim… - International Journal of …, 2023 - Elsevier
We evaluated the neuroprotective effect of L-theanine in Parkinson's disease and the
underlying mechanism focusing on WNT/β-catenin signaling mediated by the MAPK …
underlying mechanism focusing on WNT/β-catenin signaling mediated by the MAPK …
[HTML][HTML] Exendin-4 and linagliptin attenuate neuroinflammation in a mouse model of Parkinson's disease
HY Yu, T Sun, Z Wang, H Li, D Xu, J An… - Neural Regeneration …, 2023 - journals.lww.com
Use of glucagon-like peptide-1 receptor agonist or dipeptidyl peptidase 4 inhibitor has been
shown to lower the incidence of Parkinson's disease in patients with diabetes mellitus …
shown to lower the incidence of Parkinson's disease in patients with diabetes mellitus …